Patents by Inventor Rosalyn Kay Nice

Rosalyn Kay Nice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120142651
    Abstract: There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 ?g.
    Type: Application
    Filed: February 10, 2012
    Publication date: June 7, 2012
    Applicant: GlaxoSmithKline Intellectual Property Management Limited
    Inventors: Keith Biggadike, Ian Buxton, Steven John Coote, Rosalyn Kay Nice, Kenton Lewis Reed, Amyn Sayani, Avinash Chander Sharma
  • Publication number: 20100311706
    Abstract: There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 ?g.
    Type: Application
    Filed: August 18, 2010
    Publication date: December 9, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Keith Biggadike, Ian Buxton, Steven John Coote, Rosalyn Kay Nice, Kenton Lewis Reed, Amyn Sayani, Avinash Chander Sharma
  • Patent number: 7629335
    Abstract: According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
    Type: Grant
    Filed: July 6, 2006
    Date of Patent: December 8, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Patent number: 7592329
    Abstract: There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilized by the presence of a guest molecule, characterized in that the crystalline complex is of space group P212121 having unit cell dimensions of about 12.5±1.0 §, 15±1.0 §, and 16.2±1.0 § when determined at either 120K or 150K.
    Type: Grant
    Filed: February 4, 2003
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Andrew Craig, David Malcolm Crowe, Victor Witold Jacewicz, Michael John Millan, Rosalyn Kay Nice, Brian Noga, John Frederick Seager, Andrew Lewis Theophilus
  • Patent number: 7144845
    Abstract: The present invention relates to, for example, compounds of formula (VI) useful in the manufacture of anti-inflammatory androstane derivatives.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: December 5, 2006
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Patent number: 7132532
    Abstract: The present invention relates to, for example, a compound of formula (VIII) useful in the manufacture of anti-inflammatory androstane derivatives.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: November 7, 2006
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Patent number: 7125985
    Abstract: The present invention relates to, for example, a compound of formula (X) useful in the manufacture of anti-inflammatory androstane derivatives.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: October 24, 2006
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Patent number: 7101866
    Abstract: According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: September 5, 2006
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Publication number: 20040224931
    Abstract: The present invention relates to, for example, a compound of formula (X) 1
    Type: Application
    Filed: June 7, 2004
    Publication date: November 11, 2004
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Publication number: 20040225139
    Abstract: The present invention relates to, for example, a compound of formula (VIII) 1
    Type: Application
    Filed: June 7, 2004
    Publication date: November 11, 2004
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Publication number: 20040224934
    Abstract: The present invention relates to, for example, a compound of formula (XXI) 1
    Type: Application
    Filed: June 7, 2004
    Publication date: November 11, 2004
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Publication number: 20040220157
    Abstract: The present invention relates to, for example, compounds of formula (VI) 1
    Type: Application
    Filed: June 7, 2004
    Publication date: November 4, 2004
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Publication number: 20040220162
    Abstract: The present invention relates to, for example, a compound of formula (XIII) 1
    Type: Application
    Filed: June 7, 2004
    Publication date: November 4, 2004
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Publication number: 20030199485
    Abstract: According to one aspect of the invention, there is provided a compound of formula (I) 1
    Type: Application
    Filed: October 2, 2001
    Publication date: October 23, 2003
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice